Literature DB >> 14697232

Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone.

Laurence Duplomb1, Young Lee, May-Yun Wang, Byung H Park, Kiyosumi Takaishi, Anil K Agarwal, Roger H Unger.   

Abstract

To determine if increased local production of glucocorticoids by the pancreatic islets might play a role in the spontaneous noninsulin-dependent diabetes mellitus of obesity, we compared islet 11beta-HSD-1 mRNA and activity in islets of obese prediabetic and diabetic Zucker Diabetic Fatty (ZDF) (fa/fa) rats and lean wild-type (+/+) controls. In diabetic rat islets, both mRNA and enzymatic activity of the enzyme were increased in proportion to the hyperglycemia. Troglitazone (TGZ) treatment, beginning at 6 weeks of age, prevented the hyperglycemia, the hyperlipidemia, and the increase in 11beta-HSD-1. To determine if the metabolic abnormalities had caused the 11beta-HSD-1 increase, prediabetic islets were cultured in high or low glucose or in 2:1 oleate:palmitate for 3 days. Neither nutrient enhanced the expression of 11beta-HSD-1. We conclude that 11beta-HSD-1 expression and activity are increased in islets of diabetic, but not prediabetic ZDF rats, and that TGZ prevents both the increase in 11beta-HSD-1 and the diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697232     DOI: 10.1016/j.bbrc.2003.11.160

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase.

Authors:  Janine Schmid; Barbara Ludwig; Andrew V Schally; Anja Steffen; Christian G Ziegler; Norman L Block; Yassemi Koutmani; Mathias D Brendel; Katia P Karalis; Charmaine J Simeonovic; Julio Licinio; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.

Authors:  S Nair; Y H Lee; R S Lindsay; B R Walker; P A Tataranni; C Bogardus; L J Baier; P A Permana
Journal:  Diabetologia       Date:  2004-05-20       Impact factor: 10.122

Review 3.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

4.  Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.

Authors:  Sophie Turban; Xiaoxia Liu; Lynne Ramage; Scott P Webster; Brian R Walker; Donald R Dunbar; John J Mullins; Jonathan R Seckl; Nicholas M Morton
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

5.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

6.  11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.

Authors:  Chunpeng Zou; Weixin Li; Yong Pan; Zia A Khan; Jieli Li; Xixi Wu; Yi Wang; Liancheng Deng; Guang Liang; Yunjie Zhao
Journal:  Oncotarget       Date:  2017-10-24

7.  Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Moffat J Nyirenda; Roderick Carter; Justin I Tang; Annick de Vries; Christina Schlumbohm; Stephen G Hillier; Frank Streit; Michael Oellerich; Victor W Armstrong; Eberhard Fuchs; Jonathan R Seckl
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

8.  11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

Authors:  Anne Hermanowski-Vosatka; James M Balkovec; Kang Cheng; Howard Y Chen; Melba Hernandez; Gloria C Koo; Cheryl B Le Grand; Zhihua Li; Joseph M Metzger; Steven S Mundt; Heather Noonan; Christian N Nunes; Steven H Olson; Bill Pikounis; Ning Ren; Nancy Robertson; James M Schaeffer; Kashmira Shah; Martin S Springer; Alison M Strack; Matthias Strowski; Kenneth Wu; Tsueiju Wu; Jianying Xiao; Bei B Zhang; Samuel D Wright; Rolf Thieringer
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

9.  Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.

Authors:  Subrata Chowdhury; Larson Grimm; Ying Jia Kate Gong; Beixi Wang; Bing Li; Coimbatore B Srikant; Zu-hua Gao; Jun-Li Liu
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.